Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer

被引：0
|
作者：
Nicolai Mader
Christina Nguyen Ngoc
Bilge Kirkgöze
Justus Baumgarten
Daniel Groener
Konrad Klimek
Christian Happel
Nikolaos Tselis
Felix K. H. Chun
Frank Grünwald
Amir Sabet
机构：
[1] University Hospital Frankfurt,Department of Nuclear Medicine
[2] University Hospital Frankfurt,Department of Radiation Oncology
[3] University Hospital Frankfurt,Department of Urology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Prostate-specific membrane antigen (PSMA); [; Lu]Lu-PSMA; Radioligand therapy (RLT); Extended treatment; Metastatic castration-resistant prostate cancer (mCRPC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1811 / 1821
页数：10
相关论文
共 50 条
  • [31] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [32] Effectiveness of 177Lu PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Gunalp, Bengul
    Emer, Mustafa
    Ozaydin, Sukru
    Alagoz, Engin
    Ince, Semra
    Ayan, Asli
    Alkan, Sumeyye
    Mahmudov, Sarkhan
    Okuyucu, Kursat
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [33] [177Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial.
    Vaishampayan, Nitin
    Morris, Michael J.
    Krause, Bernd J.
    Vogelzang, Nicholas J.
    Kendi, Ayse T.
    Nordquist, Luke T.
    Calais, Jeremie
    Nagarajah, James
    Beer, Tomasz M.
    El-Haddad, Ghassan
    Brackman, Marcia
    Desilvio, Michelle
    Messmann, Richard Adam
    Sartor, A. Oliver
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Intensified therapy with 177Lu-PSMA-I&T in patients with high-volume metastatic castration-resistant prostate cancer
    Mader, Nicolai
    Haghghi, Sarvar
    Klimek, Konrad
    Schoeler, Christina
    Sarvestani, Mohammadreza Kamali
    Roedel, Claus
    Chun, Felix K. H.
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [35] Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"
    Radtke, Jan Philipp
    Albers, Peter
    Giesel, Frederik Lars
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [36] LuCAB: A phase I/II trial evaluating cabazitaxel in combination with [177Lu]Lu-PSMA-617 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Kostos, Louise Kathleen
    Buteau, James Patrick
    Kong, Grace
    Yeung, Theresa
    Di Iulio, Juliana
    Fahey, Michael T.
    Fettke, Heidi
    Furic, Luc
    Hofman, Michael S.
    Azad, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [37] Building a predictive model for outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data: Preliminary results.
    Herrmann, Ken
    Gafita, Andrei
    De Bono, Johann S.
    Sartor, A. Oliver
    Chi, Kim N.
    Krause, Bernd J.
    Rahbar, Kambiz
    Tagawa, Scott T.
    Czernin, Johannes
    El-Haddad, Ghassan
    Wong, Connie
    Zhang, Zhaojie
    Wilke, Celine
    Mirante, Osvaldo
    Morris, Michael J.
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 208 - 208
  • [38] [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
    Hofman, Michael S.
    Emmett, Louise
    Sandhu, Shahneen
    Iravani, Amir
    Joshua, Anthony M.
    Goh, Jeffrey C.
    Pattison, David A.
    Tan, Thean Hsiang
    Kirkwood, Ian D.
    Ng, Siobhan
    Francis, Roslyn J.
    Gedye, Craig
    Rutherford, Natalie K.
    Weickhardt, Andrew
    Scott, Andrew M.
    Lee, Sze-Ting
    Kwan, Edmond M.
    Azad, Arun A.
    Ramdave, Shakher
    Redfern, Andrew D.
    Macdonald, William
    Guminski, Alex
    Hsiao, Edward
    Chua, Wei
    Lin, Peter
    Zhang, Alison Y.
    McJannett, Margaret M.
    Stockler, Martin R.
    Violet, John A.
    Williams, Scott G.
    Martin, Andrew J.
    Davis, Ian D.
    LANCET, 2021, 397 (10276): : 797 - 804
  • [39] Promising 177Lu-PSMA-617 Therapy Results in Patients with Metastatic Castration-Resistant Prostate Cancer
    Brnjic, Antonio
    Frye, Sarah
    Botkin, Crystal
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [40] Genomic aberrations in circulating tumor DNA (ctDNA) and clinical outcomes from [177Lu] Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC)
    Fettke, Heidi
    Kostos, Louise
    Buteau, James
    Steen, Jason A.
    Medhurst, Elizabeth
    Haskali, Mo B.
    Murphy, Declan
    Docanto, Maria
    Bukczynska, Patricia
    Ng, Nicole
    Sandhu, Shahneen
    Foroughi, Siavash
    Furic, Luc
    Nguyen-Dumont, Tu
    Hofman, Michael S.
    Azad, Arun A.
    CANCER RESEARCH, 2023, 83 (07)
12345